IOC Reinstates Genetic Testing for Female Athletes at 2028 Olympics

By Daniel Richardson, Editor-in-Chief

Los Angeles – In a move sparking immediate debate, the International Olympic Committee (IOC) announced Thursday it will require chromosomal testing for all athletes competing in women’s events at the 2028 Los Angeles Olympics. The decision, reversing a policy enacted in 2021, effectively bans transgender athletes and a significant number of athletes with intersex variations from participating in women’s competitions. This marks a return to a practice last used during the Olympic Games from 1968 to 1996.

Return to Chromosomal Screening

The IOC’s decision, made during a meeting of its executive commission, stipulates that eligibility for women’s Olympic competitions is now “reserved for individuals of biological female sex,” specifically those who do not carry the SRY gene. The SRY gene is typically associated with the development of male characteristics. This policy shift represents a significant departure from the previous approach, which allowed individual international federations to establish their own guidelines regarding transgender and intersex athlete participation.

The move is the first major policy decision spearheaded by Kirsty Coventry, the Zimbabwean elected as the IOC’s president last year. While the IOC stated the policy will not be retroactive, meaning past results will not be affected, it immediately raises questions about the future of inclusivity in Olympic sport. It won’t impact Algerian boxer Imane Khelif’s gold medal from the Paris Games, as the IOC had previously acknowledged she is a female athlete despite being a carrier of the SRY gene.

How the Testing Will Work

The IOC has tasked international federations and national sporting bodies with organizing the chromosomal tests. These tests, the committee stated, will need to be conducted only once in an athlete’s lifetime. However, the practical and legal implications of implementing such a widespread testing program are already becoming apparent. In France, for example, bioethics laws currently prohibit genetic testing without a medical necessity, creating an immediate hurdle to compliance.

The decision echoes a controversial period in Olympic history. The IOC previously employed similar chromosomal testing between 1968 and the 1996 Atlanta Games before abandoning the practice in 1999. The previous tests were discontinued due to criticism regarding their invasive nature and questionable scientific validity, as well as pressure from the scientific community and the IOC’s own athletes’ commission.

Impact on Athletes

The new policy will disproportionately affect athletes with intersex conditions – variations in sex characteristics that don’t fit typical definitions of male or female. These athletes, often assigned female at birth, may naturally possess genetic variations, including the SRY gene, despite identifying and competing as women. The ban effectively excludes them from women’s Olympic competition.

The decision also effectively bars transgender women from competing in women’s events. While the IOC’s previous framework allowed for individual federations to determine their own policies, this new rule establishes a firm biological criterion for participation. This has drawn criticism from LGBTQ+ advocacy groups and athletes who argue it is discriminatory and undermines the principles of inclusivity.

Existing Policies and Precedent

Interestingly, policies mirroring this new IOC directive are already in place within three sports – athletics, boxing, and skiing – having been implemented last year. However, the application of these policies has already faced challenges, both practically and legally. The situation in France highlights the legal complexities, but similar issues are expected to arise in other countries with differing bioethical regulations.

The case of Imane Khelif, the Algerian boxer, underscores the complexities of this issue. Khelif publicly revealed she carries the SRY gene but has consistently been recognized as a female athlete. The IOC’s previous acceptance of her participation demonstrates the evolving and often contradictory nature of policies surrounding sex and gender in sport. The fact that this new rule is *not* retroactive protects her Paris medal, but future athletes in similar situations will face a different landscape.

What’s Next?

The immediate future will see international federations grappling with the logistical and legal challenges of implementing the IOC’s new policy. Expect significant debate and potential legal challenges as federations attempt to navigate the complexities of chromosomal testing and its implications for athlete eligibility. The World Athletics, International Boxing Association, and International Ski Federation will be at the forefront of this implementation process.

The IOC’s decision is likely to fuel the ongoing conversation about fairness, inclusion, and the definition of biological sex in sports. It remains to be seen how this policy will impact athlete participation and the overall landscape of Olympic competition in the years to come. The 2028 Los Angeles Games will undoubtedly be a watershed moment for the future of women’s sport.

The next key date to watch is the upcoming World Athletics Congress, where the federation is expected to discuss and finalize its implementation plan for the IOC’s new regulations. Athletes and advocacy groups will be closely monitoring these developments.

What are your thoughts on the IOC’s decision? Share your comments below.